{"id":1890,"date":"2026-11-22T13:11:03","date_gmt":"2026-11-22T13:11:03","guid":{"rendered":"https:\/\/theapnachhattisgarh.com\/?p=1890"},"modified":"2026-11-22T13:11:03","modified_gmt":"2026-11-22T13:11:03","slug":"hospital-chains-weigh-drug-price-cap-impact-as-supreme-court-scrutiny-looms-industry-news","status":"publish","type":"post","link":"https:\/\/theapnachhattisgarh.com\/?p=1890","title":{"rendered":"Hospital chains weigh drug price cap impact as Supreme Court scrutiny looms | Industry News"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div id=\"parent_top_div\" style=\"margin:0 0\">\n<p>India\u2019s leading hospital chains are divided over the potential impact of the government\u2019s cap on trade margins for oncology and other drugs, which came into effect in early November, with some expecting pressure on profitability while others see limited exposure.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The issue featured prominently in the companies\u2019 Q2FY27 earnings calls, alongside questions on a Supreme Court case concerning the commercialisation of private healthcare and the broader implications for hospital pricing and profitability.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p><strong>Fortis flags pressure on margins<\/strong><\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>Fortis Healthcare has indicated that the new pricing norms could weigh on profitability, although it is yet to quantify the impact.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The company\u2019s Chief Financial Officer, Vivek Goyal, said during its Q2 earnings call that the circular was recent and the company was still assessing its implications. Drugs account for around a third of Fortis\u2019 oncology revenue, though the price restrictions do not cover all drugs and treatment packages.<\/p>\n<p><span style=\"display:block;height:1px\">\u00a0<\/span><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The hospital chain expects its margins to remain around 22 per cent in the current financial year, after accounting for employee stock ownership plan (ESOP) costs. However, it has refrained from providing margin guidance for the next financial year, citing uncertainty around drug pricing.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p><strong>Others assess exposure<\/strong><\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>Apollo Hospitals\u2019 pharmacy arm said it is waiting for revised maximum retail prices before assessing the effect and expects \u201csome impact\u201d.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>Max Healthcare said it is still working out its exposure, adding that chemotherapy accounts for roughly 30 per cent of its oncology revenue and that part of its drug business is unaffected. Max also pointed out that the earlier revision of CGHS rates, which led it to drop some high-value chemotherapy drugs for institutional patients, is already reflected in its numbers. Jupiter Life Line Hospitals said it has not modelled the effect because it cannot influence the margin and promised a ballpark figure after the current quarter.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>Max Healthcare is also assessing its exposure. The company said chemotherapy contributes around 30 per cent of its oncology revenue, while a portion of its drug business remains outside the scope of the restrictions. It added that the impact of an earlier revision in Central Government Health Scheme (CGHS) rates, which prompted it to discontinue certain high-value chemotherapy drugs for institutional patients, has already been factored into its financial performance.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>Jupiter Life Line Hospitals said it has not yet incorporated the potential impact into its estimates, as the company has limited control over the margins. It expects to provide a broad estimate after the current quarter.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p><strong>Manipal, Aster see limited impact<\/strong><\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>In contrast, Manipal Hospitals and Aster DM Healthcare expressed relatively little concern over the new regulations.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>Manipal Hospitals Chief Executive Officer Dilip Jose said during the company\u2019s Q2 earnings call that oncology contributes around 12 per cent of the network\u2019s revenue, with chemotherapy accounting for only a portion of this. The share of drugs covered under the price restrictions is smaller still, limiting the potential impact on the overall business.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>Aster DM Healthcare Managing Director Varun Khanna said during the company\u2019s Q2 earnings call that it does not view its business primarily through the pharmacy segment and has welcomed measures aimed at making cancer treatment more affordable.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>With nearly 75 per cent of its operations in smaller cities, where access to cancer care remains limited, lower treatment costs could also support patient volumes, he said.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p><strong>Hospitals seek shift to service-based pricing<\/strong><\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The discussions also brought the debate over the pricing of private healthcare into focus, with hospital executives arguing that the industry\u2019s business model is centred on delivering integrated medical services rather than selling individual drugs.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>Apollo Hospitals Managing Director Suneeta Reddy said during the company\u2019s Q2 earnings call that drug pricing has often been used as a proxy for the services provided by hospitals, adding that the industry hopes to move towards a service-based pricing framework.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>Max Healthcare Chairman Abhay Soi said during the company\u2019s Q2 earnings call that the matter was before the Supreme Court and urged stakeholders to examine the legal pleadings rather than rely on media reports. He also highlighted that the median net profit margin for the hospital sector is around 9 per cent.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>Khanna said Aster\u2019s net profit margin was around 10 per cent and cautioned that further investments in healthcare infrastructure would depend on the sector generating adequate returns.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>India would need approximately 1.5 million additional hospital beds over the next decade, requiring investments of around $130 billion, he estimated.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>Jupiter Life Line Hospitals Chief Executive Officer Ankit Thakker declined to comment on the court proceedings, saying the company would abide by the law.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p><strong>Kerala adds to regulatory concerns<\/strong><\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>Aster also faced questions on the Kerala Assembly committee\u2019s recommendation to extend price controls across a wider range of hospital services.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>Khanna said it was difficult to anticipate the outcome of the recommendation, describing Kerala as one of the country\u2019s strongest healthcare systems. The company would engage constructively with the state government on the matter, he said.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<\/div>\n\n","protected":false},"excerpt":{"rendered":"<p>India\u2019s leading hospital chains are divided over the potential impact of the government\u2019s cap on trade margins for<\/p>\n","protected":false},"author":1,"featured_media":1891,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[21],"tags":[],"class_list":["post-1890","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-india"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.5.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"India\u2019s leading hospital chains are divided over the potential impact of the government\u2019s cap on trade margins for oncology and other drugs, which came into effect in early November, with some expecting pressure on profitability while others see limited exposure. The issue featured prominently in the companies\u2019 Q2FY27 earnings calls, alongside questions on a\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"The Apna Chhattisgarh\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/theapnachhattisgarh.com\/?p=1890\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.5.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"The Apna Chhattisgarh -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Hospital chains weigh drug price cap impact as Supreme Court scrutiny looms | Industry News - The Apna Chhattisgarh\" \/>\n\t\t<meta property=\"og:description\" content=\"India\u2019s leading hospital chains are divided over the potential impact of the government\u2019s cap on trade margins for oncology and other drugs, which came into effect in early November, with some expecting pressure on profitability while others see limited exposure. The issue featured prominently in the companies\u2019 Q2FY27 earnings calls, alongside questions on a\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/theapnachhattisgarh.com\/?p=1890\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1774264700-903.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1774264700-903.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-11-22T13:11:03+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-11-22T13:11:03+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Hospital chains weigh drug price cap impact as Supreme Court scrutiny looms | Industry News - The Apna Chhattisgarh\" \/>\n\t\t<meta name=\"twitter:description\" content=\"India\u2019s leading hospital chains are divided over the potential impact of the government\u2019s cap on trade margins for oncology and other drugs, which came into effect in early November, with some expecting pressure on profitability while others see limited exposure. The issue featured prominently in the companies\u2019 Q2FY27 earnings calls, alongside questions on a\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1774264700-903.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1890#blogposting\",\"name\":\"Hospital chains weigh drug price cap impact as Supreme Court scrutiny looms | Industry News - The Apna Chhattisgarh\",\"headline\":\"Hospital chains weigh drug price cap impact as Supreme Court scrutiny looms | Industry News\",\"author\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?author=1#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/1774264700-903.jpg\",\"width\":1200,\"height\":628},\"datePublished\":\"2026-11-22T13:11:03+00:00\",\"dateModified\":\"2026-11-22T13:11:03+00:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1890#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1890#webpage\"},\"articleSection\":\"India\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1890#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?cat=21#listItem\",\"name\":\"India\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?cat=21#listItem\",\"position\":2,\"name\":\"India\",\"item\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?cat=21\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1890#listItem\",\"name\":\"Hospital chains weigh drug price cap impact as Supreme Court scrutiny looms | Industry News\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1890#listItem\",\"position\":3,\"name\":\"Hospital chains weigh drug price cap impact as Supreme Court scrutiny looms | Industry News\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?cat=21#listItem\",\"name\":\"India\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#organization\",\"name\":\"The Apna Chhattisgarh\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/cropped-WhatsApp-Image-2026-10-24-at-10.47.40-PM.jpeg\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1890\\\/#organizationLogo\",\"width\":1597,\"height\":362},\"image\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1890\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?author=1#author\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?author=1\",\"name\":\"The Apna Chhattisgarh\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1890#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/af79d0a817c8720a95b0601916cbb419fbcc63fe5df7fc5a696773013f741e58?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"The Apna Chhattisgarh\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1890#webpage\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1890\",\"name\":\"Hospital chains weigh drug price cap impact as Supreme Court scrutiny looms | Industry News - The Apna Chhattisgarh\",\"description\":\"India\\u2019s leading hospital chains are divided over the potential impact of the government\\u2019s cap on trade margins for oncology and other drugs, which came into effect in early November, with some expecting pressure on profitability while others see limited exposure. The issue featured prominently in the companies\\u2019 Q2FY27 earnings calls, alongside questions on a\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1890#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?author=1#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?author=1#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/1774264700-903.jpg\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1890\\\/#mainImage\",\"width\":1200,\"height\":628},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1890#mainImage\"},\"datePublished\":\"2026-11-22T13:11:03+00:00\",\"dateModified\":\"2026-11-22T13:11:03+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#website\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/\",\"name\":\"The Apna Chhattisgarh\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Hospital chains weigh drug price cap impact as Supreme Court scrutiny looms | Industry News - The Apna Chhattisgarh","description":"India\u2019s leading hospital chains are divided over the potential impact of the government\u2019s cap on trade margins for oncology and other drugs, which came into effect in early November, with some expecting pressure on profitability while others see limited exposure. The issue featured prominently in the companies\u2019 Q2FY27 earnings calls, alongside questions on a","canonical_url":"https:\/\/theapnachhattisgarh.com\/?p=1890","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/theapnachhattisgarh.com\/?p=1890#blogposting","name":"Hospital chains weigh drug price cap impact as Supreme Court scrutiny looms | Industry News - The Apna Chhattisgarh","headline":"Hospital chains weigh drug price cap impact as Supreme Court scrutiny looms | Industry News","author":{"@id":"https:\/\/theapnachhattisgarh.com\/?author=1#author"},"publisher":{"@id":"https:\/\/theapnachhattisgarh.com\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1774264700-903.jpg","width":1200,"height":628},"datePublished":"2026-11-22T13:11:03+00:00","dateModified":"2026-11-22T13:11:03+00:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/theapnachhattisgarh.com\/?p=1890#webpage"},"isPartOf":{"@id":"https:\/\/theapnachhattisgarh.com\/?p=1890#webpage"},"articleSection":"India"},{"@type":"BreadcrumbList","@id":"https:\/\/theapnachhattisgarh.com\/?p=1890#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/#listItem","position":1,"name":"Home","item":"https:\/\/theapnachhattisgarh.com\/","nextItem":{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/?cat=21#listItem","name":"India"}},{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/?cat=21#listItem","position":2,"name":"India","item":"https:\/\/theapnachhattisgarh.com\/?cat=21","nextItem":{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/?p=1890#listItem","name":"Hospital chains weigh drug price cap impact as Supreme Court scrutiny looms | Industry News"},"previousItem":{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/?p=1890#listItem","position":3,"name":"Hospital chains weigh drug price cap impact as Supreme Court scrutiny looms | Industry News","previousItem":{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/?cat=21#listItem","name":"India"}}]},{"@type":"Organization","@id":"https:\/\/theapnachhattisgarh.com\/#organization","name":"The Apna Chhattisgarh","url":"https:\/\/theapnachhattisgarh.com\/","logo":{"@type":"ImageObject","url":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/10\/cropped-WhatsApp-Image-2026-10-24-at-10.47.40-PM.jpeg","@id":"https:\/\/theapnachhattisgarh.com\/?p=1890\/#organizationLogo","width":1597,"height":362},"image":{"@id":"https:\/\/theapnachhattisgarh.com\/?p=1890\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/theapnachhattisgarh.com\/?author=1#author","url":"https:\/\/theapnachhattisgarh.com\/?author=1","name":"The Apna Chhattisgarh","image":{"@type":"ImageObject","@id":"https:\/\/theapnachhattisgarh.com\/?p=1890#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/af79d0a817c8720a95b0601916cbb419fbcc63fe5df7fc5a696773013f741e58?s=96&d=mm&r=g","width":96,"height":96,"caption":"The Apna Chhattisgarh"}},{"@type":"WebPage","@id":"https:\/\/theapnachhattisgarh.com\/?p=1890#webpage","url":"https:\/\/theapnachhattisgarh.com\/?p=1890","name":"Hospital chains weigh drug price cap impact as Supreme Court scrutiny looms | Industry News - The Apna Chhattisgarh","description":"India\u2019s leading hospital chains are divided over the potential impact of the government\u2019s cap on trade margins for oncology and other drugs, which came into effect in early November, with some expecting pressure on profitability while others see limited exposure. The issue featured prominently in the companies\u2019 Q2FY27 earnings calls, alongside questions on a","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/theapnachhattisgarh.com\/#website"},"breadcrumb":{"@id":"https:\/\/theapnachhattisgarh.com\/?p=1890#breadcrumblist"},"author":{"@id":"https:\/\/theapnachhattisgarh.com\/?author=1#author"},"creator":{"@id":"https:\/\/theapnachhattisgarh.com\/?author=1#author"},"image":{"@type":"ImageObject","url":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1774264700-903.jpg","@id":"https:\/\/theapnachhattisgarh.com\/?p=1890\/#mainImage","width":1200,"height":628},"primaryImageOfPage":{"@id":"https:\/\/theapnachhattisgarh.com\/?p=1890#mainImage"},"datePublished":"2026-11-22T13:11:03+00:00","dateModified":"2026-11-22T13:11:03+00:00"},{"@type":"WebSite","@id":"https:\/\/theapnachhattisgarh.com\/#website","url":"https:\/\/theapnachhattisgarh.com\/","name":"The Apna Chhattisgarh","inLanguage":"en-US","publisher":{"@id":"https:\/\/theapnachhattisgarh.com\/#organization"}}]},"og:locale":"en_US","og:site_name":"The Apna Chhattisgarh -","og:type":"article","og:title":"Hospital chains weigh drug price cap impact as Supreme Court scrutiny looms | Industry News - The Apna Chhattisgarh","og:description":"India\u2019s leading hospital chains are divided over the potential impact of the government\u2019s cap on trade margins for oncology and other drugs, which came into effect in early November, with some expecting pressure on profitability while others see limited exposure. The issue featured prominently in the companies\u2019 Q2FY27 earnings calls, alongside questions on a","og:url":"https:\/\/theapnachhattisgarh.com\/?p=1890","og:image":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1774264700-903.jpg","og:image:secure_url":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1774264700-903.jpg","og:image:width":1200,"og:image:height":628,"article:published_time":"2026-11-22T13:11:03+00:00","article:modified_time":"2026-11-22T13:11:03+00:00","twitter:card":"summary_large_image","twitter:title":"Hospital chains weigh drug price cap impact as Supreme Court scrutiny looms | Industry News - The Apna Chhattisgarh","twitter:description":"India\u2019s leading hospital chains are divided over the potential impact of the government\u2019s cap on trade margins for oncology and other drugs, which came into effect in early November, with some expecting pressure on profitability while others see limited exposure. The issue featured prominently in the companies\u2019 Q2FY27 earnings calls, alongside questions on a","twitter:image":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1774264700-903.jpg"},"aioseo_meta_data":[],"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/theapnachhattisgarh.com\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/theapnachhattisgarh.com\/?cat=21\" title=\"India\">India<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tHospital chains weigh drug price cap impact as Supreme Court scrutiny looms | Industry News\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/theapnachhattisgarh.com\/"},{"label":"India","link":"https:\/\/theapnachhattisgarh.com\/?cat=21"},{"label":"Hospital chains weigh drug price cap impact as Supreme Court scrutiny looms | Industry News","link":"https:\/\/theapnachhattisgarh.com\/?p=1890"}],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1774264700-903.jpg","_links":{"self":[{"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=\/wp\/v2\/posts\/1890","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1890"}],"version-history":[{"count":0,"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=\/wp\/v2\/posts\/1890\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=\/wp\/v2\/media\/1891"}],"wp:attachment":[{"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1890"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1890"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1890"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}